D Landau1, H Shalev, G Levy-Finer
1Department of Pediatrics, Soroka University Medical Center, Faculty of Health Sciences, Ben Gurion University of the Negev, Beer Sheva, Israel.
Factor H deficiency-hemolytic uremic syndrome (FHD-HUS) often recurs after kidney transplants. Prophylactic plasma therapy can prevent relapses and preserve kidney function in children with FHD-HUS.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Observation:
Findings:
Implications: